Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation

AM Mahmoud - Canadian journal of physiology and …, 2014 - cdnsciencepub.com
The most important reason for the non-approval and withdrawal of drugs by the Food and
Drug Administration is hepatotoxicity. Therefore, this study was undertaken to evaluate the …

Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation

AM Mahmoud - Canadian journal of physiology and …, 2014 - pubmed.ncbi.nlm.nih.gov
The most important reason for the non-approval and withdrawal of drugs by the Food and
Drug Administration is hepatotoxicity. Therefore, this study was undertaken to evaluate the …

Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation

AM Mahmoud - Canadian Journal of Physiology and Pharmacology, 2014 - cir.nii.ac.jp
抄録< jats: p> The most important reason for the non-approval and withdrawal of drugs by
the Food and Drug Administration is hepatotoxicity. Therefore, this study was undertaken to …

Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation.

AM Mahmoud - Canadian Journal of Physiology & …, 2014 - search.ebscohost.com
The most important reason for the non-approval and withdrawal of drugs by the Food and
Drug Administration is hepatotoxicity. Therefore, this study was undertaken to evaluate the …

Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPAR [gamma] and abrogation of oxidative stress and inflammation

AM Mahmoud - Canadian Journal of Physiology and Pharmacology, 2014 - go.gale.com
The most important reason for the non-approval and withdrawal of drugs by the Food and
Drug Administration is hepatotoxicity. Therefore, this study was undertaken to evaluate the …

Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation.

AM Mahmoud - Canadian Journal of Physiology and Pharmacology, 2014 - europepmc.org
The most important reason for the non-approval and withdrawal of drugs by the Food and
Drug Administration is hepatotoxicity. Therefore, this study was undertaken to evaluate the …